Evidence map›Paper›PMID 40329940›Full record

ArticleGenes & diseases2025

Genetic feature diversity of

Ruichuan Shi, Yu Cheng, Jin Wang, Na Song, Ying Chen, Zan Teng, Ling Xu, Yunpeng Liu, Xiaotian Zhao, Qiuxiang Ou and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes & diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ruichuan ShiDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Yu ChengDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Jin WangDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Na SongDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Ying ChenDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Zan TengDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Ling XuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Yunpeng LiuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Xiaotian ZhaoGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu 210032, China.
Qiuxiang OuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu 210032, China.
Peng YangGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu 210032, China.
Rui MaDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Yiting SunDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Jinglei QuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Xiujuan QuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40329940
PMCPMC12053584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.